Rethinking contraception and infection risk

Debate continues as to whether a randomized clinical trial is needed to confirm the study's results. Photo: Kristy Siegfried/PlusNews

Hormonal birth-control injections may double a woman’s risk of contracting HIV and passing it on to her partner, according to a new study. The research comes at a time when many governments are looking to scale up their family-planning programmes in a bid to reduce maternal mortality.

Hormonal contraceptives double risk of HIV

04hiv-graphic-articleInline

The most popular contraceptive for women in eastern and southern Africa, a hormone shot given every three months, appears to double the risk the women will become infected with H.I.V., according to a large study published Monday. And when it is used by H.I.V.-positive women, their male partners are twice as likely to become infected than if the women had used no contraception.

Setback for PrEP as branch of trial is halted

Photo: International Partnership for Microbicides (IPM) Another setback in microbicide research

Hopes for a female-controlled HIV prevention tool have been dealt a blow by the termination of one part of a large African trial after it failed to show effectiveness.

Zimbabwe’s Response to AIDS: 30 years later.

Unite2011

World Leaders are meeting in New York City at the United Nations (UN) General Assembly High Level Meeting on AIDS. The gathering of Heads of State and other leaders from government, the scientific community, civil society and the private sector offers a unique opportunity to review progress, share lessons learned and chart the future course of the global AIDS response. The high level meeting extends from June 6-10, 2011.

Zimbabwe’s private sector fights HIV/AIDS

Robert Tapfumaneyi is a staff writer for HAZ.

Zimbabwe’s companies have been applauded for their role in the fight against HIV/AIDS and most of the larger corporations have good HIV/AIDS policies for their workforces. Businesses face financial losses if their workers are not productive, and so Zimbabwe’s private sector companies have had to come to terms with the implications of not addressing issues of HIV/AIDS in their workforce.

ARVs as prevention must move quickly “from science to action”

IRIN Photo: IRIN Earlier initiation of HIV treatment led to a 96 percent reduction in HIV transmission to the uninfected partner.

A landmark study showing major reductions in HIV transmission among discordant couples due to early treatment may fail to have a significant impact on HIV prevention unless governments and donors are willing to turn the science into action, HIV advocates say.

Early Start of ART Reduces Risk of HIV Transmission To Partner

The HIV Prevention Trials Network (HPTN) in Washington, DC has just announced groundbreaking results from an HIV/AIDS Phase-III multi-site randomized clinical study conducted since April 2005. Results from HPTN Study 052 show that when HIV-infected individuals start taking oral antiretroviral therapy (ART) early, the chances of their uninfected sexual partners getting infected with the HIV virus are reduced by 96%! This is reportedly the first study to show that early treatment for infected individuals can help protect HIV-negative sexual partners from contracting the virus.

CALIFORNIA: “Study into HIV ‘Cure’ Seeks Volunteers”

San Francisco researchers led by Dr. Jacob Lalezari are looking for HIV-positive volunteers to participate in a groundbreaking study that uses gene therapy to modify patients’ immune systems.

ARVs: Time to roll out Plan B

Molly Gumbo, a rural woman from Seke, is a mother of two teenage boys and has been living with HIV for the past six years.

HIV Cure “Found”! Really?

By Joshua M. Dziba Executive Director, HAZ Download PDF Version A recent news headline on the online Zimbabwean news site, NewZimbabwe.com proclaimed that an “HIV cure (had been) ‘found’”.  We felt that a clarification to this report is necessary, so as to avoid giving false hope to the millions of those who are infected with… [Learn More ...]